Kalaris to Present at Stifel 2025 Annual Healthcare Conference GlobeNewswire October 30, 2025 PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced that management will present at the upcoming Stifel 2025 […]

UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 Conference Call and Webcast Scheduled for Thursday, November 6th, 2025, at 10:00 AM ET GlobeNewswire October 30, 2025 PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions

Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 GlobeNewswire October 30, 2025 BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its

T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire October 30, 2025 — Posters will review product characterization and manufacturing data on T-knife's lead program, TK-6302, a supercharged PRAME T cell receptor therapy that is advancing towards the clinic, with the filing of

Next-Generation of Optical Ethernet PHY Transceivers Deliver Precision Time Protocol and MACsec Encryption for Long-Reach Networking Microchip's new transceivers are offered at speeds up to 25 Gbps to process more data GlobeNewswire October 30, 2025 CHANDLER, Ariz., Oct. 30, 2025 (GLOBE NEWSWIRE) — The rise of smart factories, remote monitoring and connected infrastructure are increasing

Lifetime Brands Announces Third Quarter 2025 Financial Results Release Date and Conference Call GlobeNewswire October 30, 2025 GARDEN CITY, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT) (the “Company”), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its

AllCloud Launches AI Fusion, a Multi-Layer Framework Delivering 70% Faster AI Deployments GlobeNewswire October 30, 2025 DENVER, Oct. 30, 2025 (GLOBE NEWSWIRE) — AllCloud, a leading AI-first global cloud professional and managed services company, today announced the launch of AllCloud's AI Fusion. This powerful, multi-layer framework offers a scalable architecture and repeatable accelerators designed to

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 30, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November

Youxin Technology Ltd Completes Acquisition of Celnet GlobeNewswire October 30, 2025 GUANGZHOU, CHINA, Oct. 30, 2025 (GLOBE NEWSWIRE) — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced that on

Evaxion raises $7.2 million, extending cash runway to second half of 2027 GlobeNewswire October 30, 2025 Gross proceeds from sales of shares amounting to $4.5 million and exercise of warrants providing a further $2.7 million Total gross inflow of cash of $14.7 million since the end of the second quarter 2025 Evaxion now has cash